세계의 핵산 샘플 준비 시장 : 산업 규모, 점유율, 동향, 기회 및 예측, 제품 유형별, 기술별, 치료 분야별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Nucleic Acid Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users, By Region & Competition, 2020-2030F
상품코드:1728075
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 핵산 샘플 준비 시장은 2024년 26억 5,000만 달러로 평가되었고, 2030년에는 38억 6,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 CAGR 6.45%로 성장할 전망입니다.
이 시장은 생명과학 및 진단 산업에서 다양한 생물학적 원천으로부터 DNA 및 RNA의 효율적인 추출, 정제, 준비를 가능하게 함으로써 중요한 역할을 수행합니다. 시장 성장은 분자 진단 기술의 적용 확대, 유전체 연구의 확장, 전 세계적인 맞춤형 의료로의 전환에 힘입고 있습니다. 전 세계 실험실에서 효율적이고 확장 가능한 워크플로우에 대한 수요가 증가함에 따라 기업들은 자동화, 혁신, 전략적 협력을 통해 임상 및 연구 환경의 요구사항을 충족시키는 고효율 솔루션을 제공하기 위해 투자하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
26억 5,000만 달러
시장 규모(2030년)
38억 6,000만 달러
CAGR(2025-2030년)
6.45%
급성장 부문
자기 비드 기반 기술
최대 시장
북미
시장 성장 촉진요인
감염병 관리에서 핵산 검사 활용 증가
주요 시장 과제
고급 샘플 준비 기술의 높은 비용
주요 시장 동향
자동화 및 고처리량 시스템 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 핵산 샘플 준비 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품 유형별(소모품, 시스템, 액세서리, 컴포넌트)
기술별(스핀 컬럼 기반 기술, 자기 비드 기반 기술, 기타)
치료 분야별(종양학, 감염증, 인류 유전학 및 집단 유전학, 기타)
용도별(유전체학, 단백질체학, 기타)
최종 사용자별(학술연구기관, 제약 및 생명 공학 기업, 임상 및 진단연구소, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 핵산 샘플 준비 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 핵산 샘플 준비 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 핵산 샘플 준비 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 핵산 샘플 준비 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 핵산 샘플 조제 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
합병과 인수
제13장 세계의 핵산 샘플 준비 시장 : SWOT 분석
제14장 경쟁 구도
BGI Group
F. Hoffmann:La Roche Ltd
Danaher Corporation
Eppendorf SE
BIONEER CORPORATION
Endress Hauser Group Services AG
Merck KGaA
Norgen Biotek Corp.
Aurora Biomed Inc.
Agilent Technologies, Inc.
제15장 전략적 제안
제16장 기업 소개와 면책사항
HBR
영문 목차
영문목차
The Global Nucleic Acid Sample Preparation Market was valued at USD 2.65 Billion in 2024 and is projected to reach USD 3.86 Billion by 2030, growing at a CAGR of 6.45% during the forecast period. This market plays a vital role in the life sciences and diagnostics industry by enabling the efficient extraction, purification, and preparation of DNA and RNA from various biological sources. Market growth is fueled by the increasing application of molecular diagnostics, the expansion of genomic research, and the global shift toward personalized medicine. As laboratories worldwide demand more efficient and scalable workflows, companies are investing in automation, innovation, and strategic collaborations to deliver high-throughput solutions that address the needs of both clinical and research environments.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.65 Billion
Market Size 2030
USD 3.86 Billion
CAGR 2025-2030
6.45%
Fastest Growing Segment
Magnetic-Bead Based Technology
Largest Market
North America
Key Market Drivers
Increased Use of Nucleic Acid Testing in Infectious Disease Management
The expanding use of nucleic acid-based testing for infectious disease management is a primary growth driver in the market. Nucleic acid tests (NATs), including RT-PCR, are now central to disease surveillance and diagnostics due to their sensitivity and accuracy. This shift from traditional diagnostic techniques has increased demand for reliable nucleic acid preparation products. According to data from the Institute for Health Metrics and Evaluation, 85 pathogens were responsible for 704 million disability-adjusted life years (DALYs) in 2019, highlighting the vast global disease burden and the urgent need for precise molecular diagnostics. During the COVID-19 pandemic, the importance of rapid viral RNA extraction was underscored, leading to a global uptick in demand for sample preparation kits and systems. This growing reliance on NATs in public health, hospital labs, and point-of-care settings continues to propel market demand for advanced sample prep technologies.
Key Market Challenges
High Cost of Advanced Sample Preparation Technologies
One of the core challenges in this market is the high cost associated with advanced nucleic acid preparation technologies. Automated systems, next-generation sequencing (NGS) compatible platforms, and specialized consumables can impose significant financial burdens on laboratories. These costs hinder the widespread adoption of such technologies, especially in low- and middle-income countries where healthcare budgets are limited. As a result, many laboratories may opt for manual or lower-cost alternatives, restricting the market's reach and delaying the broader implementation of molecular diagnostics and precision medicine.
Key Market Trends
Integration of Automation and High-Throughput Systems
The integration of automation and high-throughput technologies is a defining trend within the nucleic acid sample preparation market. Automated systems streamline complex workflows, increase throughput, and reduce human error, making them essential in clinical diagnostics and research applications. These platforms, often powered by robotics and AI-driven software, enable laboratories to handle larger volumes of samples efficiently. Automation also enhances reproducibility and consistency in results, which is vital for applications in genomics, infectious disease testing, and precision medicine. As the cost of automation technology becomes more accessible, its adoption is expected to rise significantly across a range of laboratory settings.
Key Market Players
BGI Group
F. Hoffmann-La Roche Ltd
Danaher Corporation
Eppendorf SE
BIONEER CORPORATION
Endress+Hauser Group Services AG
Merck KGaA
Norgen Biotek Corp.
Aurora Biomed Inc.
Agilent Technologies, Inc.
Report Scope:
In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Nucleic Acid Sample Preparation Market, By Product:
Consumables
Systems
Accessories & Components
Nucleic Acid Sample Preparation Market, By Technology:
Spin-Column Based Technology
Magnetic-Bead Based Technology
Others
Nucleic Acid Sample Preparation Market, By Therapeutics Area:
Oncology
Infectious Disease
Human Genetics/Population Genetics
Others
Nucleic Acid Sample Preparation Market, By Application:
Genomics
Proteomics
Others
Nucleic Acid Sample Preparation Market, By End User:
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Clinical and Diagnostic Laboratories
Other
Nucleic Acid Sample Preparation Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.
Available Customizations:
Global Nucleic Acid Sample Preparation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Nucleic Acid Sample Preparation Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables, Systems, Accessories & Components)
5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
5.2.4. By Application (Genomics, Proteomics, Others)
5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Nucleic Acid Sample Preparation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Therapeutics Area
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Therapeutics Area
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Therapeutics Area
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Therapeutics Area
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Nucleic Acid Sample Preparation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Therapeutics Area
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Therapeutics Area
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. United Kingdom Nucleic Acid Sample Preparation Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Therapeutics Area
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Italy Nucleic Acid Sample Preparation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Therapeutics Area
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. France Nucleic Acid Sample Preparation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Therapeutics Area
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Therapeutics Area
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Therapeutics Area
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Nucleic Acid Sample Preparation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Therapeutics Area
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Nucleic Acid Sample Preparation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Therapeutics Area
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Therapeutics Area
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Therapeutics Area
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Therapeutics Area
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Nucleic Acid Sample Preparation Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Therapeutics Area
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Therapeutics Area
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Therapeutics Area
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Therapeutics Area
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Therapeutics Area
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Therapeutics Area
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Therapeutics Area
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Therapeutics Area
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis
